INVESTER I FORTE BIOSCIENCES MED ENDAVU: Køb Forte Biosciences ($37T) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Forte Biosciences, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune and autoimmune-related diseases. Its current lead product candidate is FB102, a proprietary anti-CD122 monoclonal antibody being advanced for a range of immune-mediated conditions, including vitiligo, alopecia areata, celiac disease, graft-versus-host disease, and type 1 diabetes. The company’s work centers on targeted immunology research and drug development, with an emphasis on addressing diseases driven by abnormal immune activity. Based in Dallas, Texas, Forte Biosciences operates within the biotechnology sector and plays a role in advancing potential treatments for dermatology and broader autoimmune medicine.